StonvexLoading…
StonvexStonvexStonvexCore line items from CPSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $7.03M | $32.60M | $24.39M | $15.58M |
Operating Income | $-522.63K | $443.97K | $542.66K | $266.58K |
Net Income | $-294.18K | $420.35K | $407.76K | $199.79K |
EPS (Diluted) | $-0.02 | $0.03 | $0.03 | $0.01 |
Total Assets | $29.11M | $29.51M | $20.44M | $19.37M |
Total Liabilities | $4.70M | $4.88M | $5.30M | $4.49M |
Cash & Equivalents | $5.72M | $4.47M | $3.23M | $2.37M |
Free Cash Flow OCF − CapEx | $-767.79K | $-487.02K | $7.42K | $-869.38K |
Shares Outstanding | 18.01M | 17.99M | 14.53M | 14.53M |